Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_assertion description "[The objective of this study was to use a potent new-generation MEK inhibitor PD0325901 to further investigate the therapeutic potential of specifically targeting MEK in the MAP kinase pathway for thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_assertion evidence source_evidence_literature NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_assertion SIO_000772 18651802 NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_assertion wasDerivedFrom befree-20140225 NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_assertion wasGeneratedBy ECO_0000203 NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP881757.RAHQmdvgwxvoJ4_3wNc3ofy6zVyLDScYldbaOnbqL8A4I130_provenance.